维普中文期刊产品整合服务
29篇 您的检索式:作者名="GLUND M"
    题名 作者 年代 出处 被引量
1Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer显示文摘Glunde K Artemov D Penet M F 2010Chem Rev2010,110,5:1
2Approx?imate geodesic distances reveal biologically relevant structures in microarray data显示文摘NILSSONJ FIORETOS T W GLUND M 2004Bioinforrnarics2004,,6:1
3DICTRA, a tool for simulation of diffusional transformations in alloys显示文摘Annika Borgenstam Lars H?glund John ?gren Anders Engstr?m 2000Journal of Phase Equilibria2000,,3:1
4Idarucizumab, a specific antidote for dabigatran: immediate, complete and sustained reversal of dabigatran induced anticoagulati6n in elderly and renally impaired subjects 显示文摘Glund S Stangier J Schmohl M 2014Blood2014,124,:1
5Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry显示文摘Martin H?glund Fredrik Sandin Karin Hellstr?m Mats Bj?reman Magnus Bj?rkholm Mats Brune Arta Dreimane Marja Ekblom S?ren Lehmann Per Ljungman Claes Malm Berit Markev?rn Kristina Myhr-Eriksson Lotta Ohm Ulla Olsson-Str?mberg Anders Sj?lander Hans Wadenvik 2013Blood2013,,:1
6Further mutations in Brain 4(POU3F4) clarify the phenotype in the X linked deafness,DFN3显示文摘Bitner-Glindzicz M Turnpenny ILl{ glund P ct al 1995ttuman molecular genetics1995,4,8:1
7Matrixmetallop roteinases-2 and-9 in cervical cancer: D ifferent roles in tumor Progression显示文摘Rauvala M A glund K Puistola U 2006Int J Gynecol Cancer2006,16,3:1
8Molecular cytogenetic mapping of recurrent chromosomal breakpoints in tenosynovial giant cell tumors显示文摘Nilsson M H(o)glund M Panagopoulos I 2002Virchows Arch2002,441,5:1
9Safety,tolerability,and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healt hy male volunteers:a randomised,placebo-controlled,double-blind phase 1trial显示文摘Glund S Stangier J Schmohl M 2015The Lancet2015,386,9994:1
10Female preferences, male decision rules and the evolution of leks in the great snipe Gallinago media 显示文摘H(o)glund J Robertson J G M 1990Anim Behavv1990,40,:1
11Safety tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial显示文摘Glund S Stangier J Schmohl M 2015Lancet2015,386,9994:1
12Liver pathology associated with the use of anabolic-androgenic steroids显示文摘Soe KL Soe M Glund C 1992Liver1992,12,2:1
13There exist at least 30 human G-protein-coupled receptors with long Ser/Thr-rich N-termini显示文摘Robert Fredriksson David E.I. Gloriam P?r J. H?glund Malin C. Lagerstr?m Helgi B. Schi?th 2003Biochemical and Biophysical Research Communications2003,,3:1
14Further mutations in Brain 4 (POU3F4) clarify the phenotype in the X-linked deafness, DFN3显示文摘Bitner-Glindzicz M Turnpenny P H glund P 1995Human molecular genetics1995,4,8:1
15Safety, tolera- bility, and efficacy of Idarucizumab for the reversal of the antico- agulant effect of dabigatran in healthy male volunteers : a random- ised, placebo-controlled, double-blind phase 1 trial显示文摘GLUND S STANGIER J SCHMOHL M 2015Lancet2015,386,9994:1
16Idarucizumab, a specific antidote for dabigatran: immediate, complete and sus- tained reversal of dabigatran induced anticoagulatiou in elderly and renally impaired subjects显示文摘GLUND S STANGIER J SCHMOHL M 2014Blood2014,124,:1
17DICTRA, a tool for simulation of diffusional transformations in alloys显示文摘Annika Borgenstam Lars H?glund John ?gren Anders Engstr?m 2000Journal of Phase Equilibria2000,,3:1
18Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells显示文摘MORI N GLUNDE K TAKAGI T RAMAN V BHUJWALLA Z M 2007Cancer Res2007,67,11:1
19Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells显示文摘SHAH T WILDES F PENET M F WINNARD P T JR GLUNDE K ARTEMOV D 2010NMR Biomed2010,23,:1
20Matrixmetallop roteinases- 2 and-9 in cervical cancer: D ifferent roles in tumor p rogression 显示文摘Rauvala M A glund K Puistola U 2006Int J Gynecol Cancer2006,16,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费